Today’s Viruses for Today’s Tests.
Axenica Bioscience manufactures well-characterized viral reference materials from recent clinical isolates, enabling diagnostic developers and public health researchers to study how their assays recognize viruses circulating today.
The problem
Viruses keep changing, but many of the many of the virus strains used to develop and challenge diagnostic tests were collected years or decades ago. As that gap grows, a test can quietly lose accuracy against new variants, and the first sign that a diagnostic test is falling behind may be a missed infection.
What we make
Ready-to-use vials of characterized virus. Every lot comes with a Certificate of Analysis covering three levels of characterization:
Whole-genome sequencing
The virus’s complete genetic code, so you know exactly which strain you are testing against.
Copy number
How much viral genetic material is in each vial, measured by digital PCR.
Infectious titer
How much live virus was present before processing, for consistent, comparable lots.
Representative product images.
Where we are
- Biosafety Level 2 laboratory in Buffalo, New York
- First products: influenza A (H1N1 and H3N2) and influenza B, planned for 2027
- Next: RSV, SARS-CoV-2, and more
- Quality system built from day one to ISO 13485, the international quality standard for medical devices
- 2026 FuzeHub Commercialization Competition finalist
Today’s viruses · Well characterized · Made to demand · Built with public-health partners · Quality from day one
Leadership
Kelly Cycon, PhD
Co-founder, President & Chief Scientific Officer
Kelly is a virologist and life-science commercialization leader experienced in infectious-disease reference materials, assay-support products and customer development. She holds a PhD in Immunology from the University at Buffalo and a BS in Biotechnology from Rochester Institute of Technology. She previously served as the head of virology at ZeptoMetrix for 15 years, sourcing, productizing, and testing virus strains and as Vice President at iFyber. She leads Axenica’s science, quality system and partner network.
Part of New York’s life science community
Investors and partners
Meet us at the New York State Innovation Summit, October 27–28, at the Buffalo Convention Center.
All Axenica products are for Research Use Only. Not for use in diagnostic procedures.